Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Dermatofibrosarcoma × Chemotherapy, Adjuvant × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Rectal Neoplasms 5 Lung Neoplasms 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Colonic Neoplasms 3 Central Nervous System Neoplasms 3 Breast Neoplasms, Male 3 Brain Neoplasms 3 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioblastoma 2 Breast Carcinoma In Situ 2 Vomiting 1 Teratoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nausea 1 Medulloblastoma 1

Interventions

Doxorubicin 4 pazopanib 2 Ifosfamide 2 saracatinib 1 sapanisertib 1 indolepropanol phosphate 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 MLN 8237 1 Imatinib Mesylate 1 HhAntag691 1 Gene Expression Profiling 1 Dexrazoxane 1 Blotting, Western 1 Albumin-Bound Paclitaxel 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡